Iliac Stent Market Size, Share, and Forecast Report 2024

"The Business Research Company recently released a comprehensive report on the Global Iliac Stent Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15827&type=smp

According to The Business Research Company's, The iliac stent market size has grown strongly in recent years. It will grow from $0.95 billion in 2023 to $1.02 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to expansion of the global healthcare industry, increased awareness about minimally invasive procedures, increased demand for stenting procedures, rise in incidence of iliac artery diseases, improved healthcare infrastructure.

The iliac stent market size is expected to see strong growth in the next few years. It will grow to $1.34 billion in 2028 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to increasing prevalence of peripheral artery diseases, growing geriatric population, increasing angioplasty operations, rise in the need for less intrusive operations, rising incidence of diabetes. Major trends in the forecast period include technological advancements in iliac stents, increasing number of product approvals, advancements in medical technology, expanding distribution networks, adoption of iliac stents in outpatient settings.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/iliac-stent-global-market-report

Market Drivers and Trends:

Major companies operating in the iliac stent market are developing innovative products such as iCast to improve patient outcomes and reduce the risk of complications. iCast-covered stent system represents an innovative approach to treating iliac artery occlusive disease, offering improved performance and reduced risk of complications compared to traditional bare-metal stents. For instance, in October 2023, Getinge, a Sweden-based healthcare company, announced the commercial availability of the iCast-covered stent system in the USA for treating iliac arterial occlusive disease approved by the Food and Drug Administration (FDA). This indication reflects Getinge's commitment to bringing high-quality products and support to US clinicians and hospital systems to treat this severe condition.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc, C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH, Vascular Concepts Limited, Lombard Medical Technologies , Acandis GmbH, Gore Medical, Medizintechnik GmbH

Iliac Stent Market 2024 Key Insights:

• The iliac stent market size is expected to see strong growth in the next few years. It will grow to $1.34 billion in 2028 at a compound annual growth rate (CAGR) of 7%.
• Rising Prevalence of Peripheral Artery Diseases Fuels The Iliac Stent Market
• Advancements In Iliac Stent Technologies With FDA Approval Enhances Safety, Innovation, and Accessibility
• North America was the largest region in the iliac stent market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=15827&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.